Clinical Trials

Current Clinical Trials

Large Diameter ViSiGi LUX ™ Gastric Sizing and Calibration System
  1. Steve Choe, MD
    Steve Choe, MD
  2. for people 18 and up (full criteria)
  3. Rancho Mirage, CA
  4. study started June 2029
  5. Steve Choe, MD
  6. Accepting new patients

Description

Summary

Patients with a planned laparoscopic gastric surgery are candidates for this study of the 52 Fr ViSiGi LUX. During certain laparoscopic gastric surgical procedures, a tube may be passed through a patient's mouth into their stomach and is connected to suction to empty the contents of the stomach. This tube then allows the surgeon to determine the size of the patient's esophagus and stomach. The device being investigated in this study is an update to ViSiGi LUX that is currently used in thousands of procedures each year. This new investigational ViSiGi LUX, called 52 Fr ViSiGi LUX, has near infrared lights that emit specific light that can be seen on the robotic camera that the surgeon will use to see inside the abdomen during the procedure. These lights allow the surgeon to clearly see through the stomach tissue to decide where to place the ViSiGi LUX. This new device has a larger diameter than ViSiGi LUX equivalent to weighted bougies normally used in certain gastric procedures. There will be 10 subjects enrolled in this study.

Official Title

Large Diameter ViSiGi LUX ™ Gastric Sizing and Calibration System Usability Study

Keywords

Candidate for laparoscopic or robotic gastric surgery

Eligibility

for people 18 and up
Inclusion Criteria•18 years or older•Able to consent•Candidate for laparoscopic or robotic gastric surgeryExclusion Criteria•Esophageal stricture that does not allow passage of the device•Conditions which would preclude gastric surgical procedures•Pregnant patients... more
less

Inclusion Criteria
•18 years or older
•Able to consent
•Candidate for laparoscopic or robotic gastric surgery
Exclusion Criteria
•Esophageal stricture that does not allow passage of the device
•Conditions which would preclude gastric surgical procedures
•Pregnant patients

Lead Scientist at Eisenhower Health

Steve Choe, MD
Dr. Choe earned his Medical Degree from Drexel University College of Medicine in Philadelphia, PA. He completed his General Surgery residency at Hahnemann University Hospital in Philadelphia, then continued with sub-specialty training in minimally invasive surgery at The Allegheny Health, Network Esophageal and Lung Institute in Pittsburgh. He completed a Fellowship in Advanced Foregut Surgery, using the latest endoscopic, laparoscopic, and assisted techniques available to treat esophageal and g... more
less

Dr. Choe earned his Medical Degree from Drexel University College of Medicine in Philadelphia, PA. He completed his General Surgery residency at Hahnemann University Hospital in Philadelphia, then continued with sub-specialty training in minimally invasive surgery at The Allegheny Health, Network Esophageal and Lung Institute in Pittsburgh. He completed a Fellowship in Advanced Foregut Surgery, using the latest endoscopic, laparoscopic, and assisted techniques available to treat esophageal and gastric disease.

In discussing patient care, Dr. Choe states, “Many patients want to understand what is happening clinically. I see my role in educating the patient about their illness or disease, and how it’s affecting their health. I present options to the patient, allowing them to make an informed decision about their treatment and health care.”

Initially, Dr. Choe thought he would specialize in pediatrics; however, during medical school rotations, he became intrigued with the possibility of expediting the healing process through surgical intervention. Dr. Choe shares, “I became very interested and excited to be able to address an illness or disease through surgery; bringing health and healing back to the patient.”

In his clinical practice, Dr. Choe is a skilled General Surgeon, specializing in esophageal and gastric diseases. His commitment to advanced medical and surgical treatment is evidenced by his training and utilization of the daVinci® Surgical System for robot assisted, minimally invasive surgeries. The daVinci® technology offers a less invasive technique than traditional surgery (open) and allows surgeries to be performed through a few, small incisions. Using the daVinci® Surgery technology may allow patients to have less need for pain medication, smaller incisions for minimal scarring, a shorter hospital stay and faster recovery. Dr. Choe completed his fellowship training in Advanced Endoscopic and Laparoscopic Treatment of esophageal and gastric cancer, hiatal hernias, esophageal motility disorders, and gastroesophageal reflux disease.

Clinical Study Details

  1. Accepting new patients
  2. study started June 2029
  3. Interventional
  4. June 16, 2026
Cookie Disclaimer:

By using or otherwise accessing the website, you agree to that this website uses cookies and similar technologies, including those provided by vendors, for various purposes, such as to support website performance, features, and analytics (for example, Google Analytics). These cookies may process data such as IP addresses, including for them to function properly. Cookie vary across the website, including per webpage. For more information, see the Website Privacy Policy. Use or other access to this website is subject to the Website Terms and Conditions.

Accept ALL cookies to enhance your experience, including analytics that help us understand how our site is used. Accept Required allows only essential cookies needed for the website to function, such as session management and your cookie preferences. Accept None does not allow any non-essential cookies and no cookies are stored after your session is complete. Modify My Preferences